Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy

Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy

Testicular cancer is predominantly curable, but the long-term side effects of chemotherapy have a severe impact on life quality. In this research study, we focus on hearing loss as a part of overall chemotherapy-induced ototoxicity. This is a unique approach where we combine clinical data from the a...

Full description

Bibliographic Details
Main Authors: Sara L. Garcia, Jakob Lauritsen, Bernadette K. Christiansen, Ida F. Hansen, Mikkel Bandak, Marlene D. Dalgaard, Gedske Daugaard, Ramneek Gupta
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Cancers
Subjects:
chemotherapy regimen
genetics
testicular cancer
hearing loss
machine learning
Online Access:https://www.mdpi.com/2072-6694/15/15/3923

Internet

https://www.mdpi.com/2072-6694/15/15/3923

Similar Items